-
Entity
-
Individual
-
Location
-
C/O Brookside Capital, Llc, John Hancock Tower, 200 Clarendon St, Boston, Massachusetts
-
Summary
-
The estimated net worth of Adam Koppel is at least $2.8B dollars as of January 12, 2024. Adam Koppel is the Director, More than 10% owner of Cerevel Therapeutics Holdings, Inc. and owns shares of Cerevel Therapeutics Holdings, Inc. (CERE) worth about $2.77B. Adam Koppel is the Director, More than 10% owner of Solid Biosciences Inc. and owns shares of Solid Biosciences Inc. (SLDB) worth about $22.3M. Adam Koppel is the Director of Foghorn Therapeutics Inc. and owns shares of Foghorn Therapeutics Inc. (FHTX) worth about $49K.